Comparable Transactions
The same headline royalty rate implies very different economics depending on the asset, rights, and risk profile. DataAlchemist connects rates to the licensed asset, terms, territory, and exclusivity.
DataAlchemist helps valuation and advisory teams understand the economic reality behind comparable licensing transactions.
Designed for professionals who need more than a royalty rate: agreement terms, payment structures, rights granted, technical context, market evidence, and source-linked evidence for valuation judgment.
The objective is not to replace valuation judgment. It is to give professionals better evidence for that judgment, connecting royalty rates, agreements, and technical context into a clear transaction profile.
The same headline royalty rate implies very different economics depending on the asset, rights, and risk profile. DataAlchemist connects rates to the licensed asset, terms, territory, and exclusivity.
License agreements often describe assets incompletely. We enrich transactions with context from patents, filings, and regulatory materials to transform thin agreement language into valuation-ready evidence.
The value of an intangible depends on the rights being transferred. We structure key terms like exclusivity, field of use, duration, and sublicensing to clarify passive ownership versus active technology control.
Valuation and deal advisory teams need to understand the full economic structure of a license.
DataAlchemist captures more than running royalties. Records can include normalized royalty bases, upfront fees, milestones, tiered rates, minimums, and hybrid structures, as disclosed in the source agreement.
For reasonable royalty analysis, PPA, licensing negotiations, and transaction support, the payment structure can be as important as the headline rate. It is the full consideration, not the number that gets quoted.
Edgar captures the economic profile behind each comparable: payment structure, rights granted, asset context, and the evidence beyond the headline rate that valuation judgment depends on.
In pharma and med-device licensing, development stage materially affects valuation. We reconstruct regulatory context from source materials so users can distinguish early-stage and approved assets appropriately.
DataAlchemist supports acquisition analysis by connecting licensing comparables, service arrangements, and lease benchmarks for intangible asset valuation, contributory asset charges, and broader transaction support.
Valuation conclusions are only as defensible as their evidence. We link transactions to agreements, filings, and Evidence Packs, supporting a clear narrative for expert reports, disputes, and audit review.
Built for teams that need to explain the economic reality behind a comparable transaction.
Use comparable licensing transactions, royalty economics, payment structures, and market context for IP valuation, intangible asset valuation, and PPA.
Support acquisition analysis, purchase price allocation, contributory asset charge work, and transaction diligence with market-based benchmark evidence.
Use source-linked comparables and evidence trails for reasonable royalty analysis, damages support, expert reports, and disputes.
Review licensing benchmarks, rights granted, exclusivity, payment structures, and commercialization context for negotiation and strategy.
Valuation and deal teams need to defend a conclusion, not just retrieve a rate, supported by cleaner comparables, stronger evidence trails, and normalized economic context.
See how DataAlchemist supports IP valuation, PPA, reasonable royalty analysis, technology transfer, and deal advisory with comparable licensing transactions and source-linked evidence.
Request a Valuation Walkthrough